Novavax Inc (NVV1)

Frankfurt
Currency in EUR
8.26
-0.03(-0.36%)
Closed
NVV1 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
8.258.26
52 wk Range
3.3323.93
Key Statistics
Edit
Bid/Ask
8.16 / 8.20
Prev. Close
8.29
Open
8.25
Day's Range
8.25-8.26
52 wk Range
3.33-23.93
Volume
300
Average Volume (3m)
3.24K
1-Year Change
123.85%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NVV1 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
3 analysts have revised their earnings downwards for the upcoming period
Show more

Novavax Inc Company Profile

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Employees
1543
Market
Germany

Compare NVV1 to Peers and Sector

Metrics to compare
NVV1
Peers
Sector
Relationship
P/E Ratio
−4.7x−4.7x−0.6x
PEG Ratio
−0.07−0.010.00
Price/Book
−2.6x1.2x2.6x
Price / LTM Sales
1.5x11.6x3.1x
Upside (Analyst Target)
-217.8%53.6%
Fair Value Upside
Unlock20.8%8.0%Unlock

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the Novavax (NVV1) Stock Price Today?

The Novavax stock price today is 8.26.

What Stock Exchange Does Novavax Trade On?

Novavax is listed and trades on the Frankfurt stock exchange.

What Is the Stock Symbol for Novavax?

The stock symbol for Novavax is "NVV1."

What Is the Novavax Market Cap?

As of today, Novavax market cap is 1.31B.

What is Novavax Earnings Per Share?

The Novavax EPS is -1.99.

From a Technical Analysis Perspective, Is NVV1 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.